- Home
- CNTX vs BRID Comparison
CNTX vs BRID Comparison
Compare CNTX & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- BRID
- Stock Information
- Founded
- CNTX 2015
- BRID 1932
- Country
- CNTX United States
- BRID United States
- Employees
- CNTX N/A
- BRID N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- BRID Specialty Foods
- Sector
- CNTX Health Care
- BRID Consumer Staples
- Exchange
- CNTX Nasdaq
- BRID Nasdaq
- Market Cap
- CNTX 78.0M
- BRID 70.3M
- IPO Year
- CNTX 2021
- BRID N/A
- Fundamental
- Price
- CNTX $0.58
- BRID $7.65
- Analyst Decision
- CNTX Strong Buy
- BRID
- Analyst Count
- CNTX 4
- BRID 0
- Target Price
- CNTX $6.00
- BRID N/A
- AVG Volume (30 Days)
- CNTX 390.0K
- BRID 1.9K
- Earning Date
- CNTX 08-06-2025
- BRID 06-02-2025
- Dividend Yield
- CNTX N/A
- BRID N/A
- EPS Growth
- CNTX N/A
- BRID N/A
- EPS
- CNTX N/A
- BRID N/A
- Revenue
- CNTX N/A
- BRID $224,673,000.00
- Revenue This Year
- CNTX N/A
- BRID N/A
- Revenue Next Year
- CNTX N/A
- BRID N/A
- P/E Ratio
- CNTX N/A
- BRID N/A
- Revenue Growth
- CNTX N/A
- BRID N/A
- 52 Week Low
- CNTX $0.49
- BRID $7.52
- 52 Week High
- CNTX $2.75
- BRID $14.69
- Technical
- Relative Strength Index (RSI)
- CNTX 44.00
- BRID 40.57
- Support Level
- CNTX $0.56
- BRID $7.64
- Resistance Level
- CNTX $0.63
- BRID $7.88
- Average True Range (ATR)
- CNTX 0.08
- BRID 0.17
- MACD
- CNTX 0.00
- BRID -0.01
- Stochastic Oscillator
- CNTX 27.68
- BRID 6.38
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About BRID Bridgford Foods Corporation
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.